Cini John K. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Cini John K.
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-07-02+78,214→ 238,071 total
Footnotes (1)
- [F1]On July 2, 2020, the Reporting Person was granted 78,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022.